Comparative effects of macro-sized aluminum oxide and aluminum oxide nanoparticles on erythrocyte hemolysis: influence of cell source, temperature, and size
Source abstract
Abstract
Al2O3 is the most abundantly produced nanomaterial and has been used in diverse fields, including the medical, military and industrial sectors. As there are concerns about the health effects of nanoparticles, it is important to understand how they interact with cells, and specifically with red blood cells. The hemolysis induced by three commercial nano-sized aluminum oxide particles (nanopowder 13 nm, nanopowder <50 nm and nanowire 2-6 nm × 200-400 nm) was compared to aluminum oxide and has been studied on erythrocytes from humans, rats and rabbits, in order to elucidate the mechanism of action and the influence of size and shape on hemolytic behavior. The concentrations inducing 50% hemolysis (HC50) were calculated for each compound studied. The most hemolytic aluminum oxide particles were of nanopowder 13, followed by nanowire and nanopowder 50. The addition of albumin to PBS induced a protective effect on hemolysis in all the nano-forms of Al2O3, but not on Al2O3. The drop in HC50 correlated to a decrease in nanomaterial size, which was induced by a reduction of aggregation Aluminum oxide nanoparticles are less hemolytic than other oxide nanoparticles, and behave differently depending on the size and shape of the nanoparticles. The hemolytic behavior of aluminum oxide nanoparticles differs from that of aluminum oxide.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Erythrocyte Function and Pathophysiology · Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Ansari MA, Khan HM, Khan AA, Cameotra SS, Saquib Q, Musarrat J (2014) Interaction of Al2O3 nanoparticles with Escherichia coli and their cell envelope biomolecules. J Appl Microbiol 116:772–78310.1111/jam.12423 ↗
2. Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Hussain SM, Grover P (2010) In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol In Vitro 24:1871–187610.1016/j.tiv.2010.07.004 ↗
3. Barshtein G, Arbell D, Yedgar S (2011) Hemolytic effect of polymeric nanoparticles: role of albumin. IEEE Trans. Nanobiosci 10:259–26110.1109/TNB.2011.2175745 ↗
4. Chen LQ, Kang B, Ling J (2013) Cytotoxicity of cuprous oxide nanoparticles to fish blood cells: hemolysis and internalization. J Nanopart Res 15(3):150710.1007/s11051-013-1507-7 ↗
5. Chithrani BD, Chan WCW (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542–155010.1021/nl070363y ↗
6. Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA (2011) Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 123:133–14310.1093/toxsci/kfr149 ↗
7. Di Virgilio AL, Reigosa M, Arnal PM, Fernández Lorenzo de Mele M (2010) Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells. J Hazard Mater 177:711–71810.1016/j.jhazmat.2009.12.089 ↗
8. Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE (2008) Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180–218710.1021/nl0805615 ↗
9. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, Weber TJ (2007) Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100:303–31510.1093/toxsci/kfm217 ↗
10. Harley JD, Margolis J (1961) Haemolytic activity of colloidal silica. Nature 189:1010–101110.1038/1891010a0 ↗
11. Hedberg Y, Gustafsson J, Karlsson HL, Möller L, Wallinder IO (2010) Bioaccessibility, bioavailability and toxicity of commercial relevant iron- and chromium-based particles: in vitro studies with an inhalation perspective. Part Fibre Toxicol 7:2310.1186/1743-8977-7-23 ↗
12. Jiang W, Kim BY, Rutka JT, Chan WC (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–15010.1038/nnano.2008.30 ↗
13. Kapralov AA, Feng WH, Amoscato AA, Yanamala N, Balasubramanian K, Winnica DE, Kisin ER, Kotchey GP, Gou P, Sparvero LJ, Ray P, Mallampalli RK, Klein-Seetharaman J, Fadeel B, Star A, Shvedova AA, Kagan VE (2012) Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 6:4147–415610.1021/nn300626q ↗
14. Koziara JM, Oh JJ, Akers WS, Ferraris SPM, Mumper RJ (2005) Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 22:1821–182810.1007/s11095-005-7547-7 ↗
15. Lu S, Duffin R, Poland C, Daly P, Murphy F, Drost E, Macnee W, Stone V, Donaldson K (2009) Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ Health Perspect 117:241–24710.1289/ehp.11811 ↗
16. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–1427010.1073/pnas.0805135105 ↗
17. Mahmoudi M, Abdelmonem AM, Behzadi S, Clement JH, Dutz S, Ejtehadi MR, Hartmann R, Kantner K, Linne U, Maffre P, Metzler S, Moghadam MK, Pfeiffer C, Rezaei M, Ruiz-Lozano P, Serpooshan V, Shokrgozar MA, Nienhaus GU, Parak WJ (2013) Temperature: the “ignored” factor at the nanobio interface. ACS Nano 7:6555–656210.1021/nn305337c ↗
18. Majedi SM, Kelly BC, Lee HK (2014) Role of combinatorial environmental factors in the behavior and fate of ZnO nanoparticles in aqueous systems: a multiparametric analysis. J Hazard Mater 264:370–37910.1016/j.jhazmat.2013.11.015 ↗
19. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011) Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–253410.1021/ja107583h ↗
20. Nel L, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–55710.1038/nmat2442 ↗
21. Nogueira DR, Mitjans M, Infante MR, Vinardell MP (2011) The role of counterions in the membrane-disruptive properties of pH-sensitive lysine-based surfactants. Acta Biomater 7:2846–285610.1016/j.actbio.2011.03.017 ↗
22. Patra TK, Singh JK (2014) Polymer directed aggregation and dispersion of anisotropic nanoparticles. Soft Matter 10:1823–183010.1039/c3sm52216d ↗
23. Rittner MN (2002) Market analysis of nanostructured materials. Am Ceramic Soc Bull 81:33–36
24. Sadiq IM, Pakrashi S, Chandrasekaran N, Mukherjee A (2011) Studies on toxicity of aluminum oxide (Al2O3) nanoparticles to microalgae species: Scenedesmus sp. and Chlorella sp. J Nanopart Res 13(8):3287–329910.1007/s11051-011-0243-0 ↗
25. Saha K, Moyano DF, Rotello VM (2014) Protein coronas suppress the hemolytic activity of hydrophilic and hydrophobic nanoparticles. Mater Horiz 1:102–10510.1039/C3MH00075C ↗
26. Sharma H, Kumar K, Choudhary C, Mishra PK, Vaidya B (2014) Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug. Artif Cells Nanomed Biotechnol. Early Online: 1–8
27. Shi J, Hedberg Y, Lundin M, Odnevall Wallinder I, Karlsson HL, Möller L (2012) Hemolytic properties of synthetic nano- and porous silica particles: the effect of surface properties and the protection by the plasma corona. Acta Biomater 8:3478–349010.1016/j.actbio.2012.04.024 ↗
28. Simon-Deckers A, Gouget B, Mayne-L’hermite M, Herlin-Boime N, Reynaud C, Carrière M (2008) In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 253:137–14610.1016/j.tox.2008.09.007 ↗
29. Slowing II, Wu CW, Vivero-Escoto JL, Lin VS (2009) Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5:57–6210.1002/smll.200800926 ↗
30. Trpkovic A, Todorovic-Markovic B, Kleut D, Misirkic M, Janjetovic K, Vucicevic L, Pantovic A, Jovanovic S, Dramicanin M, Markovic Z, Trajkovic V (2010) Oxidative stress-mediated hemolytic activity of solvent exchange-prepared fullerene (C60) nanoparticles. Nanotechnology 37:37510210.1088/0957-4484/21/37/375102 ↗
31. Tyner KM, Schiffman SR, Giannelis EP (2004) Nanobiohybrids as delivery vehicles for camptothecin. J Control Release 95:501–51410.1016/j.jconrel.2003.12.027 ↗
32. Verma A, Stellaci F (2010) Effect of surface properties on nanoparticle-cell interactions. Small 6:12–2110.1002/smll.200901158 ↗
33. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA (2010) What the cell “sees” in bionanoscience. J Am Chem Soc 132:5761–576810.1021/ja910675v ↗
34. Yamamoto A, Honda R, Sumita M, Hanawa T (2004) Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res 68:244–25610.1002/jbm.a.20020 ↗
35. Yu T, Malugin A, Ghandehari H (2011) Impact of silica nanoparticles design on cellular toxicity and hemolytic activity. ACS Nano 5:5717–572810.1021/nn2013904 ↗
36. Zhang XQ, Yin LH, Tang M, Pu YP (2011) ZnO, TiO2, SiO2 and Al2O3 nanoparticles-induced toxic effects on human fetal lung fibroblasts. Biomed Environ Sci 24:661–669
37. Zook JM, Maccuspie RI, Locascio LE, Halter MD, Elliott JT (2011) Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology 5:517–53010.3109/17435390.2010.536615 ↗